GSK (GSK) reported Q4 earnings Wednesday of 0.23 British pounds ($0.29) per share, down from 0.29 pounds a year earlier.
An analyst polled by FactSet expected 0.20 pounds.
Sales for the quarter ended Dec. 31 were 8.12 billion pounds compared with 8.05 billion pounds a year earlier.
Analysts surveyed by FactSet estimated 7.78 billion.
GSK maintained its Q4 dividend at 0.16 pounds per share to be paid on April 10 to holders as of Feb. 21.
The company said it expects 2025 EPS to increase by 6% to 8% on sales growth of 3% to 5%. Analysts surveyed by FactSet estimate 1.55 pounds in core EPS on revenue of 31.10 billion pounds.
The company also approved a 2 billion pound share buyback program for the next 18 months.
Shares of the company were up over 5% in recent pre-market activity.
Price: 36.72, Change: +1.88, Percent Change: +5.40
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。